Skip to content
ClinCalc Pro
Menu
Antacid

Magnesium trisilicate with Mg carbonate & NaHCO3

Brand names: Magnesium Trisilicate Mixture BP

This antacid combines magnesium trisilicate, magnesium carbonate and sodium bicarbonate to provide short-term relief of dyspepsia, heartburn and acid-related indigestion.

Dosing — no UK product information found

We found no UK product information (SmPC) for this medicine or presentation on the eMC or MHRA Products (checked October 2026). It may be unlicensed in the UK, imported, a medical device, or no longer marketed. ClinCalc Pro shows only doses it can trace to official product information, so none is shown — follow your specialist service or local guideline.

Clinical monograph

How it works

The magnesium salts and sodium bicarbonate neutralise gastric acid and raise intragastric pH, while magnesium trisilicate also reacts to form a gelatinous silica that offers a degree of mucosal protection.

Prescribing in practice

  • The sodium bicarbonate content gives a significant sodium load, so it should be used with caution in hypertension, heart failure and other conditions requiring sodium restriction.
  • Magnesium salts may accumulate and cause toxicity in renal impairment, and the magnesium component tends to be mildly laxative.
  • Antacids can reduce the absorption of many oral drugs, so doses should be separated from other medicines.

Monitoring

No routine monitoring is needed for occasional use, but review sodium intake and renal function if used regularly or in susceptible patients.

Counselling the patient

  • Take doses separately from your other tablets, leaving a gap between them.
  • This product contains sodium, so mention it if you are on a low-salt diet or have heart or kidney problems.
  • See your prescriber if indigestion is persistent or recurrent rather than relying on long-term self-treatment.

Evidence & guidelines

Compound magnesium and bicarbonate antacids are long-standing symptomatic treatments for dyspepsia; persistent or alarm-feature symptoms warrant assessment as advised by NICE dyspepsia guidance.

Reference: Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.